Despite amino acids contributing minimally to myocardial energy metabolism, it has also been demonstrated that glucose can contribute to cardiac hypertrophy by preventing Kruppel-like factor 15 regulated transcription, thereby reducing branched chain amino acid metabolism and increasing mammalian target of rapamycin activation (Shao et al., 2018). The gene discussed is MTOR; the disease is cardiac hypertrophy.